GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Visioneering Technologies Inc (ASX:VTI) » Definitions » Peter Lynch Fair Value

Visioneering Technologies (ASX:VTI) Peter Lynch Fair Value : A$-3.73 (As of Mar. 29, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Visioneering Technologies Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, Visioneering Technologies's PEG is 1. Visioneering Technologies's 5-Year TTM EBITDA Growth Rate is 25. Visioneering Technologies's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was A$-0.15. Therefore, the Peter Lynch Fair Value for today is A$-3.73.

As of today (2025-03-29), Visioneering Technologies's share price is A$0.066. Visioneering Technologies's Peter Lynch fair value is A$-3.73. Therefore, Visioneering Technologies's Price to Peter Lynch Fair Value Ratio for today is N/A.


The historical rank and industry rank for Visioneering Technologies's Peter Lynch Fair Value or its related term are showing as below:



ASX:VTI's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.76
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Visioneering Technologies Peter Lynch Fair Value Historical Data

The historical data trend for Visioneering Technologies's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visioneering Technologies Peter Lynch Fair Value Chart

Visioneering Technologies Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Peter Lynch Fair Value
Get a 7-Day Free Trial - - - - -

Visioneering Technologies Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Visioneering Technologies's Peter Lynch Fair Value

For the Medical Devices subindustry, Visioneering Technologies's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Visioneering Technologies's Price-to-Peter-Lynch-Fair-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Visioneering Technologies's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Visioneering Technologies's Price-to-Peter-Lynch-Fair-Value falls into.


;
;

Visioneering Technologies Peter Lynch Fair Value Calculation

Visioneering Technologies's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 25 *-0.149
=-3.73

For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Visioneering Technologies's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was A$-0.15.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Visioneering Technologies  (ASX:VTI) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 25 instead of 15 in this case.

Visioneering Technologies's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=0.066/-3.73
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Visioneering Technologies Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Visioneering Technologies's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Visioneering Technologies Business Description

Traded in Other Exchanges
N/A
Address
30 Mansell Court, Suite 215, Alpharetta, GA, USA, 30076
Visioneering Technologies Inc is a medical device company. It designs, manufactures, sells, and distributes its NaturalVue daily disposable multifocal contact lenses for adults with Presbyopia and children with Myopia. The company offers NaturalVue MF contact lenses. Its Multifocal contact lens provides Presbyopia patients with near, intermediate, and distance vision, making it much easier for eye care professionals to fit their patients. It has two reportable segments; North America which includes its operations in the United States and Canada; and Europe/Asia Pacific which includes its operations outside North America.

Visioneering Technologies Headlines

From GuruFocus

Gleason Group, Inc. Goes on Buying Spree in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-11-2023

McClarren Financial Advisors, Inc.'s Top 5 Buys of the 3rd Quarter

By GuruFocus Research GuruFocus Editor 11-01-2022

Top 5 3rd Quarter Trades of Gibson Wealth Advisors LLC

By GuruFocus Research GuruFocus Editor 11-23-2022

HERITAGE INVESTORS MANAGEMENT CORP's Top 5 Buys of the 4th Quarter

By GuruFocus Research GuruFocus Editor 02-06-2023

Top 5 4th Quarter Trades of H&H Retirement Design & Management INC

By GuruFocus Research GuruFocus Editor 01-17-2023

Top 5 3rd Quarter Trades of VISTA CAPITAL PARTNERS, INC.

By GuruFocus Research GuruFocus Editor 11-08-2022

Top 5 4th Quarter Trades of Greenfield Savings Bank

By GuruFocus Research GuruFocus Editor 01-13-2023

Northstar Group, Inc. Buys 2, Sells 3 in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-26-2023

AGILIS PARTNERS LLC Buys 1, Sells 4 in 4th Quarter

By GuruFocus Research GuruFocus Editor 02-07-2023

Top 5 4th Quarter Trades of OPPENHEIMER ASSET MANAGEMENT INC.

By GuruFocus Research GuruFocus Editor 02-07-2023